|
Q1 FY2027
As of Jul 31, 2026
|
Q4 FY2026
As of Apr 30, 2026
|
Q3 FY2026
As of Jan 31, 2026
|
Q2 FY2026
As of Oct 31, 2025
|
Q1 FY2026
As of Jul 31, 2025
|
Q4 FY2025
As of Apr 30, 2025
|
Q3 FY2025
As of Jan 31, 2025
|
Q2 FY2025
As of Oct 31, 2024
|
Q1 FY2025
As of Jul 31, 2024
|
Q4 FY2024
As of Apr 30, 2024
|
Q3 FY2024
As of Jan 31, 2024
|
Q2 FY2024
As of Oct 31, 2023
|
Q1 FY2024
As of Jul 31, 2023
|
Q4 FY2023
As of Apr 30, 2023
|
Q3 FY2023
As of Jan 31, 2023
|
Q2 FY2023
As of Oct 31, 2022
|
Q1 FY2023
As of Jul 31, 2022
|
Q4 FY2022
As of Apr 30, 2022
|
Q3 FY2022
As of Jan 31, 2022
|
Q2 FY2022
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowances of $39 at July 31, 2026 and at April 30, 2026 | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid income taxes | ||||||||||||||||||||
| Prepaid expenses and other | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Deferred taxes | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Cash surrender value of life insurance and assets held in trust | ||||||||||||||||||||
| Right-of-use assets – operating leases | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY: | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accounts payable – trade | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Loss provision accrual | ||||||||||||||||||||
| Dividend payable | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Operating lease liability, current portion | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred compensation | ||||||||||||||||||||
| Deferred taxes | ||||||||||||||||||||
| Operating lease liability, non-current portion | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Contingencies (Note 15) | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock - $1.00 par value; authorized 600 shares, no shares issued and outstanding | ||||||||||||||||||||
| Common stock - $1.00 par value; authorized 20,000 shares, 11,017 shares issued and 10,961 shares outstanding at July 31, 2026; 9,925 shares issued and 9,869 shares outstanding at April 30, 2026 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Common stock reacquired and held in treasury - at cost (56 shares at July 31, 2026 and at April 30, 2026) | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
